These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38626363)

  • 1. Glucose Control and Risk of Symptomatic Intracerebral Hemorrhage Following Thrombolysis for Acute Ischemic Stroke: A SHINE Trial Analysis.
    Southerland AM; Mayer SA; Chiota-McCollum NA; Bolte AC; Pauls Q; Pettigrew LC; Bleck TP; Conaway M; Johnston KC
    Neurology; 2024 May; 102(9):e209323. PubMed ID: 38626363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
    Johnston KC; Bruno A; Pauls Q; Hall CE; Barrett KM; Barsan W; Fansler A; Van de Bruinhorst K; Janis S; Durkalski-Mauldin VL;
    JAMA; 2019 Jul; 322(4):326-335. PubMed ID: 31334795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of functional outcome after symptomatic intracranial hemorrhage complicating intravenous thrombolysis: results from the SITS-ISTR.
    Tsivgoulis G; Palaiodimou L; Stefanou MI; Theodorou A; Kõrv J; Nunes AP; Candelaresi P; Dall'Ora E; Sariaslani P; Provinciali L; Conforto AB; Cidrao AAL; Karapanayiotides T; Ahmed N
    Eur J Neurol; 2023 Oct; 30(10):3161-3171. PubMed ID: 37410547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex difference in the association between triglyceride and intracerebral bleeding risk after intravenous thrombolysis for acute ischemic stroke, a multi-center retrospective study.
    Yuan Q; Han Y; Fang S; Lei H; Huang H; Lin H; Wu X; Chen R; Chen Z; Chen J; Li H; Liu N; Du H
    PeerJ; 2024; 12():e17558. PubMed ID: 38938613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk score for prediction of symptomatic intracerebral haemorrhage following thrombolysis.
    Soni M; Wijeratne T; Ackland DC
    Int J Med Inform; 2021 Dec; 156():104586. PubMed ID: 34649112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke.
    Masrur S; Cox M; Bhatt DL; Smith EE; Ellrodt G; Fonarow GC; Schwamm L
    J Am Heart Assoc; 2015 Sep; 4(10):e002193. PubMed ID: 26408015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.
    Kamal H; Mehta BK; Ahmed MK; Kavak KS; Zha A; Lail NS; Shirani P; Al-Mufti F; Sawyer RN; Mowla A
    J Neurol Sci; 2021 Jan; 420():117265. PubMed ID: 33333324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
    JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.
    Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M
    Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.
    Southerland AM; Johnston KC
    Ann N Y Acad Sci; 2012 Sep; 1268(1):72-8. PubMed ID: 22994224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Depletion Coagulopathy Predicts Major Bleeding After Thrombolysis for Ischemic Stroke: A Multicenter Study.
    Romoli M; Vandelli L; Bigliardi G; Naccarato M; Moller J; Balestrino M; Giammello F; Gentile M; Dell'Acqua ML; Manganotti P; Forlivesi S; Melis M; Picchetto L; Rosafio F; Furlanis G; Testoni S; Piras V; Malfatto L; Musolino RF; Scali I; Maffei S; Migliaccio L; Trenti T; Mancini R; Marietta M; Randi V; Meletti S; Zini A
    Stroke; 2022 Dec; 53(12):3671-3678. PubMed ID: 36039754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants for a low dose of alteplase and its relationship to a lower intracerebral bleeding risk in acute ischemic stroke.
    Chen J; Li H; Lei H; Fang S; Yuan Q; Chen Y; Chen D; Chen R; Zhang Y; Wei J; Chen G; Chen Z; Liu N; Du HW
    Int J Med Sci; 2022; 19(12):1762-1769. PubMed ID: 36313231
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.
    Lansberg MG; Albers GW; Wijman CA
    Cerebrovasc Dis; 2007; 24(1):1-10. PubMed ID: 17519538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.